Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity

Archives of Ophthalmology

Volumn 130, Issue 6, 2012, Pages 801-802

  Patel, Ravi D ^a   Blair, Michael P ^a,b,d   Shapiro, Michael J ^b,d   Lichtenstein, Steven J ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

^d Retina Consultants Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ARTICLE; CASE REPORT; HUMAN; LOW LEVEL LASER THERAPY; NEWBORN; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; SEDATION; TREATMENT FAILURE;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DISEASE PROGRESSION; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INTRAVITREAL INJECTIONS; RECURRENCE; RETINAL DETACHMENT; RETINOPATHY OF PREMATURITY; TREATMENT FAILURE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862234277     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.1802     Document Type: Article

References (5)

1. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol. 1988;106(4):471-479.
2. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the Early Treatment for Retinopathy of Prematurity randomized trial. Arch Ophthalmol. 2003;121(12):1684-1694.
3. Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364(7):603-615.
4. Moshfeghi DM, Berrocal AM. Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice. Ophthalmology. 2011;118(7):1227-1228.
5. Lalwani GA, Berrocal AM, Murray TG, et al. Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity [published correction appears in Retina. 2009;29(1):127]. Retina. 2008;28(3)(suppl):S13-S18. (Pubitemid 351644418)